Evidence map›Paper›PMID 21808621›Full record

ArticleFrontiers in physiology2011

Why Do CD8+ T Cells become Indifferent to Tumors: A Dynamic Modeling Approach.

Colin Campbell, Ranran Zhang, Jeremy S Haley, Xin Liu, Thomas Loughran, Todd D Schell, Réka Albert, Juilee Thakar

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Advances in systems immunology and cancer.Frontiers in physiology · 2014
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Colin CampbellDepartment of Physics, The Pennsylvania State University University Park, PA, USA.
Ranran Zhang
Jeremy S Haley
Xin Liu
Thomas Loughran
Todd D Schell
Réka Albert
Juilee Thakar
Pennsylvania State University · USPenn State Milton S. Hershey Medical Center · USYale University · US

Funding

CD8+ T Cell-Mediated Immunotherapy of Autochthonous SV40 T Antigen-Induced TumorsR01CA025000 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI SCHELL, TODD D · 1985 to 2014
$5.0M
NCI NIH HHS R01 CA025000
6 · The paper itself

Abstract

CD8+ T cells have the potential to influence the outcome of cancer pathogenesis, including complete tumor eradication or selection of malignant tumor escape variants. The Simian virus 40 large T-antigen (Tag) oncoprotein promotes tumor formation in Tag-transgenic mice and also provides multiple target determinants (sites) for responding CD8+ T cells in C57BL/6 (H-2(b)) mice. To understand the in vivo quantitative dynamics of CD8+ T cells after encountering Tag, we constructed a dynamic model from in vivo-generated data to simulate the interactions between Tag-expressing cells and CD8+ T cells in distinct scenarios including immunization of wild-type C57BL/6 mice and of Tag-transgenic mice that develop various tumors. In these scenarios the model successfully reproduces the dynamics of both the Tag-expressing cells and antigen-specific CD8+ T cell responses. The model predicts that the tolerance of the site-specific T cells is dependent on their apoptosis rates and that the net growth of CD8+ T cells is altered in transgenic mice. We experimentally validate both predictions. Our results indicate that site-specific CD8+ T cells have tissue-specific apoptosis rates affecting their tolerance to the tumor antigen. Moreover, the model highlights differences in apoptosis rates that contribute to compromised CD8+ T cell responses and tumor progression, knowledge of which is essential for development of cancer immunotherapy.

Indexed as

apoptosis and proliferation ratesCD8+ T cellsdynamic modelT-antigentumor

Identifiers

PMID21808621
PMCPMC3135868
OpenAlexW1979394677

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.